Mavacoxib (trade name Trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease.

[2] It acts as a COX-2 inhibitor.

[3] Mavacoxib, along with several other COX-2 selective inhibitors, including celecoxib, valdecoxib, and parecoxib, were discovered by a team at the Searle division of Monsanto led by John Talley.

This veterinary medicine–related article is a stub.

You can help Wikipedia by expanding it.This drug article relating to the musculoskeletal system is a stub.